drugset / Trial / NCT04842331
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
RandomizedParallel-groupOpen-labelPrevention
Summary
This is an open label controlled household-randomised trial designed to evaluate the efficacy of RESP301 alongside standard of care ("SOC") versus SOC alone.
Timeline
- Start
- 2021-09
- Primary completion
- 2022-01
- Completion
- 2022-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mannitol | Diagnostic / imaging agent | — | Inhaled |
| Subject | Sodium Nitrite | Small molecule | — | Inhaled |
| Subject | citric acid | Unknown | — | Inhaled |